前收市價 | 1.6500 |
開市 | 1.6500 |
買盤 | 1.0000 |
賣出價 | 3.1000 |
拍板 | 59.00 |
到期日 | 2024-06-28 |
今日波幅 | 1.6500 - 1.6500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 11 |
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
There are a handful of different factors that could buoy its stock.
With the interest cuts coming up, it’s an ideal time to consider loading up on the top biotech stocks. These stocks continue to dazzle with game-changing medical breakthroughs and explosive growth potential. Though they can be speculative, a select few biotech stocks to buy can deliver substantial long-term returns for those willing to stomach the risk. Biotech stocks can be remarkably risky due to the lengthy and uncertain drug development process, regulatory roadblocks, and other issues. Their